Additionally, metformin successfully diminished the ability of EAC cell lines to develop tumor spheres as well as reduced the fraction of ALDH-1 positive cells, suggesting that it can be used to target the CSCs. This evidence concerns the gene ALDH1A1 and neoplasm.